Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$14.25 - $30.93 $1.24 Million - $2.69 Million
-87,042 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$10.43 - $17.8 $907,848 - $1.55 Million
87,042 New
87,042 $1.25 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $208M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track G2 Investment Partners Management LLC Portfolio

Follow G2 Investment Partners Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of G2 Investment Partners Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on G2 Investment Partners Management LLC with notifications on news.